ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $10,994,000 | -29.7% | 269,876 | +6.5% | 0.07% | -9.0% |
Q4 2019 | $15,631,000 | -15.4% | 253,473 | 0.0% | 0.08% | -23.5% |
Q3 2019 | $18,473,000 | -23.8% | 253,473 | -14.0% | 0.10% | -24.4% |
Q2 2019 | $24,236,000 | +43.1% | 294,852 | +22.8% | 0.14% | +37.8% |
Q1 2019 | $16,941,000 | +60.1% | 240,166 | +2.2% | 0.10% | +48.5% |
Q4 2018 | $10,579,000 | -13.3% | 234,995 | +8.9% | 0.07% | +1.5% |
Q3 2018 | $12,195,000 | +25.3% | 215,695 | +48.0% | 0.06% | +16.1% |
Q2 2018 | $9,732,000 | +14.7% | 145,695 | 0.0% | 0.06% | +16.7% |
Q1 2018 | $8,482,000 | -9.7% | 145,695 | 0.0% | 0.05% | -5.9% |
Q4 2017 | $9,390,000 | -52.1% | 145,695 | -61.0% | 0.05% | -54.5% |
Q3 2017 | $19,610,000 | +11.3% | 373,595 | -0.7% | 0.11% | +8.7% |
Q2 2017 | $17,615,000 | +27.9% | 376,395 | +35.3% | 0.10% | +25.6% |
Q1 2017 | $13,768,000 | +97.7% | 278,095 | +80.2% | 0.08% | +90.7% |
Q4 2015 | $6,964,000 | +30178.3% | 154,336 | +25622.7% | 0.04% | – |
Q3 2015 | $23,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mesirow Financial Investment Management, Inc. | 9,433 | $266,000 | 1.14% |
Global Alpha Capital Management Ltd. | 258,946 | $7,305,000 | 1.12% |
Birch Grove Capital LP | 50,791 | $1,433,000 | 0.78% |
1492 Capital Management LLC | 25,003 | $705,000 | 0.53% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 321,975 | $9,083,000 | 0.41% |
THB ASSET MANAGEMENT | 48,385 | $1,364,000 | 0.38% |
Regent Investment Management LLC | 36,979 | $1,043,000 | 0.32% |
GLOBEFLEX CAPITAL L P | 41,212 | $1,163,000 | 0.31% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $1,001,000 | 0.26% |
Ranger Investment Management | 124,763 | $3,520,000 | 0.22% |